Benzodiazepine actions mediated by specific γ-aminobutyric acidA receptor subtypes
The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
GABA(A) (gamma-aminobutyric acid(A)) receptors are molecular substrates for the regulation of vigilance, anxiety, muscle tension, epileptogenic activity and memory functions, which is evident from the spectrum of actions elicited by clinically effective drugs acting at their modulatory benzodiazepine-binding site. Here we show, by introducing a histidine-to-arginine point mutation at position 101 of the murine alpha1-subunit gene, that alpha1-type GABA(A) receptors, which are mainly expressed in cortical areas and thalamus, are rendered insensitive to allosteric modulation by benzodiazepine-site ligands, whilst regulation by the physiological neurotransmitter gamma-aminobutyric acid is preserved. alpha1(H101R) mice failed to show the sedative, amnesic and partly the anticonvulsant action of diazepam. In contrast, the anxiolytic-like, myorelaxant, motor-impairing and ethanol-potentiating effects were fully retained, and are attributed to the nonmutated GABA(A) receptors found in the limbic system (alpha2, alpha5), in monoaminergic neurons (alpha3) and in motoneurons (alpha2, alpha5). Thus, benzodiazepine-induced behavioural responses are mediated by specific GABA(A) receptor subtypes in distinct neuronal circuits, which is of interest for drug design.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Based on in vivo point mutations, a-1-GABA A receptors have been found to mediate sedation and anterograde amnesia and to partially mediate anticonvulsant activity, whereas a-2-GABA A receptors mediate anxiolysis (14,15).”
From Benzodiazepines in epilepsy: Pharmacology and pharmacokinetics (2008) · cites this paper as [15]
In the citing paper
“There is also evidence suggesting the involvement of α1GABAARs [62, 63], α2GABAARs [50], and α4/δGABAARs in learning and memory [64-68].”
From An emerging circuit pharmacology of GABAA receptors (2018) · cites this paper as [63]
In the citing paper
“Thus, these findings may suggest a role for CA1 α1 GABAARs in memory consolidation, providing temporal and anatomical specificity to early reports that the amnestic effects of diazepam were abolished in α1 (H101R) mice, in which diazepam does not bind to α1GABAARs [63].”
From An emerging circuit pharmacology of GABAA receptors (2018) · cites this paper as [63]
In the citing paper
“Thus, these findings may suggest a role for CA1 α1 GABAARs in memory consolidation, providing temporal and anatomical specificity to early reports that the amnestic effects of diazepam were abolished in α1 (H101R) mice, in which diazepam does not bind to α1GABAARs [63].”
From An emerging circuit pharmacology of GABAA receptors (2018) · cites this paper as [63]
Citations
Cites
The use of a plus-maze to measure anxiety in the mouse
Lister, R. (1987) · Psychopharmacology · doi:10.1007/bf00177912 · Cited by 2,609
Benzodiazepine Receptor: Demonstration in the Central Nervous System
Möhler, H., & Okada, T. (1977) · Science · doi:10.1126/science.918669 · Cited by 1,700
Self-citationFritschy, J., & Mohler, H. (1995) · Journal of Comparative Neurology · doi:10.1002/cne.903590111 · Cited by 1,244
Self-citationSelective antagonists of benzodiazepines
Hunkeler, W., Möhler, H., Pieri, L., Polc, P., Bonetti, E. P., Cumin, R., Schaffner, R., & Haefely, W. (1981) · Nature · doi:10.1038/290514a0 · Cited by 1,232
Self-citationBarnard, E. A., Skolnick, P., Olsen, R. W., Möhler, H., Sieghart, W., Biggio, G., Bræstrup, C., Bateson, A. N., & Langer, S. Z. (1998) · PubMed · Cited by 1,204
Self-citationEfficient in vivo manipulation of mouse genomic sequences at the zygote stage.
Lakso, M., Pichel, J. G., Gorman, J. R., Sauer, B., Okamoto, Y., Lee, E., Alt, F. W., & Westphal, H. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.5860 · Cited by 1,125
A simple and reliable conflict procedure for testing anti-anxiety agents
Vogel, J. R., Beer, B., & Clody, D. E. (1971) · Psychopharmacologia · doi:10.1007/bf00403989 · Cited by 841
A single histidine in GABAA receptors is essential for benzodiazepine agonist binding.
Wieland, H. A., Lüddens, H., & Seeburg, P. H. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45961-3 · Cited by 447
High densities of benzodiazepine receptors in human cortical areas
BRAESTRUP, C., ALBRECHTSEN, R., & SQUIRES, R. F. (1977) · Nature · doi:10.1038/269702a0 · Cited by 414
Fritschy, J. M., Benke, D., Mertens, S., Oertel, W. H., Bachi, T., & Möhler, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.15.6726 · Cited by 344
Self-citation
Research works printed but not linked: 2
- Knoflach,F. et al. Pharmacological modulation of the diazepam-insensitive recombinant γ-aminobutyric acidA receptors α4β2γ2 and α6β2γ2. Mol. Pharmacol. 50, 1253–1261 (1996).
- Bernard,F. et al. in Zolpidem: an Update of its Pharmacological Properties and the Therapeutic Place in the Management of Insomnia (eds Freeman, H., Puech, A. J. & Roth, T.) 21–31 (Elsevier, Paris, 1996).
Cited by
Items 101–200 of 1,001
The complexity of the GABAA receptor shapes unique pharmacological profiles
D’Hulst, C., Atack, J. R., & Kooy, R. F. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.06.009 · Cited by 178
New epilepsy therapies in development
Klein, P., Kaminski, R. M., Koepp, M., & Löscher, W. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-00981-w · Cited by 154
Neurosteroids, GABAA receptors, and escalated aggressive behavior
Miczek, K. A., Fish, E. W., & De Bold, J. F. (2003) · Hormones and Behavior · doi:10.1016/j.yhbeh.2003.04.002 · Cited by 177
The Vogel conflict test: procedural aspects, γ-aminobutyric acid, glutamate and monoamines
Millan, M. J., & Brocco, M. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01275-5 · Cited by 177
Correction of respiratory disorders in a mouse model of Rett syndrome
Abdala, A. P. L., Dutschmann, M., Bissonnette, J. M., & Paton, J. F. R. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1012104107 · Cited by 174
γ-Aminobutyric acid A receptor subunit mutant mice: new perspectives on alcohol actions
Boehm, S. L., Ponomarev, I., Jennings, A. W., Whiting, P. J., Rosahl, T. W., Garrett, E. M., Blednov, Y. A., & Harris, R. A. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.07.023 · Cited by 173
Hypnosedative-Induced Complex Behaviours: Incidence, Mechanisms and Management
Dolder, C. R., & Nelson, M. H. (2008) · CNS Drugs · doi:10.2165/0023210-200822120-00005 · Cited by 172
Prenosil, G. A., Schneider Gasser, E. M., Rudolph, U., Keist, R., Fritschy, J.-M., & Vogt, K. E. (2006) · Journal of Neurophysiology · doi:10.1152/jn.01199.2005 · Cited by 171
Self-citationMajor Differences in Inhibitory Synaptic Transmission onto Two Neocortical Interneuron Subclasses
Bacci, A., Rudolph, U., Huguenard, J. R., & Prince, D. A. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-29-09664.2003 · Cited by 171
Self-citationSaari, T. I., Uusi‐Oukari, M., Ahonen, J., & Olkkola, K. T. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.002717 · Cited by 170
Odor Discrimination Requires Proper Olfactory Fast Oscillations in Awake Mice
Lepousez, G., & Lledo, P.-M. (2013) · Neuron · doi:10.1016/j.neuron.2013.07.025 · Cited by 169
Kralic, J. E., O’Buckley, T. K., Khisti, R. T., Hodge, C. W., Homanics, G. E., & Morrow, A. L. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00174-0 · Cited by 168
The Pharmacology and Mechanisms of Action of New Generation, Non-Benzodiazepine Hypnotic Agents
Sanger, D. J. (2004) · CNS Drugs · doi:10.2165/00023210-200418001-00004 · Cited by 168
Molecular targets in the treatment of anxiety
Kent, J. M., Mathew, S. J., & Gorman, J. M. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01672-4 · Cited by 167
RO4938581, a novel cognitive enhancer acting at GABAA α5 subunit-containing receptors
Ballard, T. M., Knoflach, F., Prinssen, E. P. M., Borroni, E., Vivian, J. A., Basile, J., Gasser, R., Moreau, J., Wettstein, J. G., Buettelmann, B., et al. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1357-7 · Cited by 167
Yu, Z.-Y., Wang, W., Fritschy, J.-M., Witte, O. W., & Redecker, C. (2006) · Brain Research · doi:10.1016/j.brainres.2006.04.118 · Cited by 166
Self-citationGenetic animal models of anxiety
Finn, D. A., Rutledge-Gorman, M. T., & Crabbe, J. C. (2003) · Neurogenetics · doi:10.1007/s10048-003-0143-2 · Cited by 166
Neuroactive steroid effects on cognitive functions with a focus on the serotonin and GABA systems
Birzniece, V., Bäckström, T. C., Johansson, I., Lindblad, C., Lundgren, P., Löfgren, M., Olsson, T., Ragagnin, G., Taube, M., Türkmen, Ş., et al. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2005.11.001 · Cited by 166
Urraca, N., Cleary, J., Brewer, V., Pivnick, E. K., McVicar, K., Thibert, R. L., Schanen, N. C., Esmer, C., Lamport, D., & Reiter, L. T. (2013) · Autism Research · doi:10.1002/aur.1284 · Cited by 164
“A similar pattern is typically seen in children treated with benzodiazepines or barbiturates, both of which promote GABA(A) receptors in the brain [T.R. Browne & Penry, 1973; Rudolph et al., 1999; Rudolph & Knoflach, 2011], but none of our subjects were on these medications.”
BackgroundGenetic basis of anxiety-like behaviour: a critical review
Clément, Y., Calatayud, F., & Belzung, C. (2002) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00637-2 · Cited by 164
Searching for perfect sleep: the continuing evolution of GABA A receptor modulators as hypnotics
Nutt, D. J., & Stahl, S. M. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881109106927 · Cited by 163
Good night and good luck: Norepinephrine in sleep pharmacology
Mitchell, H. A., & Weinshenker, D. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.10.004 · Cited by 163
Chronic Pain States: Pharmacological Strategies to Restore Diminished Inhibitory Spinal Pain Control
Zeilhofer, H. U., Benke, D., & Yevenes, G. E. (2012) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010611-134636 · Cited by 162
Self-citationGABA-A2 receptor subunit gene (GABRA2) polymorphisms and risk for alcohol dependence
Soyka, M., Preuss, U. W., Hesselbrock, V., Zill, P., Koller, G., & Bondy, B. (2008) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2006.11.006 · Cited by 162
Gaboxadol — a new awakening in sleep
Wafford, K. A., & Ebert, B. (2005) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2005.10.004 · Cited by 162
An update for epilepsy research and antiepileptic drug development: Toward precise circuit therapy
Wang, Y., & Chen, Z. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.05.010 · Cited by 161
Linalool Odor-Induced Anxiolytic Effects in Mice
Harada, H., Kashiwadani, H., Kanmura, Y., & Kuwaki, T. (2018) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2018.00241 · Cited by 161
Neuroadaptive processes in GABAergic and glutamatergic systems in benzodiazepine dependence
Allison, C., & Pratt, J. A. (2003) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(03)00029-9 · Cited by 160
Chuang, S.-H., & Reddy, D. S. (2017) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.117.244673 · Cited by 160
GENETIC APPROACHES TO THE STUDY OF ANXIETY
Gordon, J. A., & Hen, R. (2004) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.27.070203.144212 · Cited by 160
Mechanisms of neurosteroid interactions with GABAA receptors
Akk, G., Covey, D. F., Evers, A. S., Steinbach, J. H., Zorumski, C. F., & Mennerick, S. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.03.004 · Cited by 159
Molecular regulation of cognitive functions and developmental plasticity: impact of GABAAreceptors
Möhler, H. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04454.x · Cited by 159
Self-citationColacicco, G., Welzl, H., Lipp, H., & Würbel, H. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00391-6 · Cited by 159
Role of GABAAreceptors in the physiology and pharmacology of sleep
Winsky‐Sommerer, R. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.06716.x · Cited by 159
Identification of a Novel, Selective GABAAα5 Receptor Inverse Agonist Which Enhances Cognition
Chambers, M. S., Atack, J. R., Broughton, H. B., Collinson, N., Cook, S. M., Dawson, G. R., Hobbs, S. C., Marshall, G. R., Maubach, K. A., Pillai, G. V., et al. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm020582q · Cited by 157
Creed, M. C., Ntamati, N. R., & Tan, K. R. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00008 · Cited by 157
GABAA receptor subtypes: any clues to the mechanism of benzodiazepine dependence?
Wafford, K. A. (2004) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2004.08.006 · Cited by 154
The neurobiology of alcohol consumption and alcoholism: An integrative history
Tabakoff, B., & Hoffman, P. L. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.10.009 · Cited by 153
Criteria for Validating Mouse Models of Psychiatric Diseases
Chadman, K., Yang, M., & Crawley, J. (2009) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30777 · Cited by 140
Developmental changes in GABAergic mechanisms in human visual cortex across the lifespan
Pinto (2010) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2010.00016 · Cited by 131
Mouse strain differences in autonomic responses to stress
van Bogaert, M. J. V., Groenink, L., Oosting, R. S., Westphal, K. G. C., van der Gugten, J., & Olivier, B. (2005) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2005.00143.x · Cited by 149
GABAergic Synaptic Transmission
Draguhn, A., & Hartmann, K. (2006) · Advances in molecular and cell biology · doi:10.1016/s1569-2558(06)38009-5 · Cited by 150
GABRA2 Alleles Moderate the Subjective Effects of Alcohol, Which are Attenuated by Finasteride
Pierucci‐Lagha, A., Covault, J., Feinn, R., Nellissery, M. J., Hernández–Ávila, C. A., Oncken, C. A., Morrow, A. L., & Kranzler, H. R. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300688 · Cited by 149
GABAA receptor subtypes as targets for neuropsychiatric drug development
Korpi, E. R., & Sinkkonen, S. T. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.05.009 · Cited by 149
Anxiogenic properties of an inverse agonist selective for α 3 subunit‐containing GABAA receptors
Atack, J. R., Hutson, P. H., Collinson, N., Marshall, G., Bentley, G., Moyes, C., Cook, S. M., Collins, I., Wafford, K., McKernan, R. M., et al. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706056 · Cited by 134
Role of the PLC‐related, catalytically inactive protein p130 in GABAA receptor function
Kanematsu, T., Jang, I., Yamaguchi, T., Nagahama, H., Yoshimura, K., Hidaka, K., Matsuda, M., Takeuchi, H., Misumi, Y., Nakayama, K., et al. (2002) · The EMBO Journal · doi:10.1093/emboj/21.5.1004 · Cited by 148
Kahnberg, P., Lager, E., Rosenberg, C., Schougaard, J., Camet, L., Sterner, O., Nielsen, E. Ø., Nielsen, M., & Liljefors, T. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020839k · Cited by 147
General anaesthetic action at transmitter-gated inhibitory amino acid receptors
Belelli, D., Pistis, M., Peters, J. A., & Lambert, J. J. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01405-4 · Cited by 147
Specific GABAA circuits in brain development and therapy
Möhler, H., Fritschy, J., Crestani, F., Hensch, T. K., & Rudolph, U. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.07.025 · Cited by 146
Self-citationCarling, R. W., Moore, K. W., Street, L. J., Wild, D., Isted, C., Leeson, P. D., Thomas, S., O'Connor, D. V., McKernan, R. M., Quirk, K., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm031020p · Cited by 146
Wong, E. H. F., Yocca, F. D., Smith, M. A., & Lee, C. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710000866 · Cited by 145
Benzodiazepine Modulation of GABAA Receptors: A Mechanistic Perspective
Goldschen-Ohm, M. P. (2022) · Biomolecules · doi:10.3390/biom12121784 · Cited by 145
van Rijnsoever, C., Täuber, M., Choulli, M. K., Keist, R., Rudolph, U., Mohler, H., Fritschy, J. M., & Crestani, F. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1067-04.2004 · Cited by 144
Self-citationGoodacre, S. C., Street, L. J., Hallett, D. J., Crawforth, J. M., Kelly, S., Owens, A. P., Blackaby, W., Lewis, R. T., Stanley, J. L., Smith, A. J., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm051065l · Cited by 144
Bonne, O. B., Grillon, C., Vythilingam, M., Neumeister, A., & Charney, D. S. (2004) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2003.12.001 · Cited by 145
Modulation of rhythmic brain activity by diazepam: GABA A receptor subtype and state specificity
Kopp, C., Rudolph, U., Löw, K., & Tobler, I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0306975101 · Cited by 133
Self-citationGABAAReceptors: Properties and Trafficking
Michels, G., & Moss, S. J. (2007) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409230601146219 · Cited by 117
GABAA receptor subtypes: the ‘one glass of wine’ receptors
Olsen, R. W., Hanchar, H. J., Meera, P., & Wallner, M. (2007) · Alcohol · doi:10.1016/j.alcohol.2007.04.006 · Cited by 142
“Also, the interesting synergistic action of classical benzodiazepine agonists (like diazepam) with ethanol (Van Gorder et al., 1985; Rudolph et al., 1999; Tauber et al., 2003) remains to be explained, because none of the classical benzodiazepine agonists binds with reasonable affinity to…”
BackgroundMendelson, W. (2004) · Sleep Medicine Reviews · doi:10.1016/s1087-0792(03)00042-x · Cited by 142
GABA-A receptors: a viable target for novel anxiolytics?
Whiting, P. J. (2005) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2005.08.005 · Cited by 142
GABA receptors, progesterone and premenstrual dysphoric disorder
Poromaa, I. S., Smith, S. S., & Gulinello, M. E. (2003) · Archives of Women s Mental Health · doi:10.1007/s00737-002-0147-1 · Cited by 142
Flavonoids as GABAA receptor ligands: the whole story?
Marder, M. (2012) · Journal of Experimental Pharmacology · doi:10.2147/jep.s23105 · Cited by 141
Concepts and correlations relevant to general anaesthesia
Urban, B. W., & Bleckwenn, M. (2002) · British Journal of Anaesthesia · doi:10.1093/bja/aef164 · Cited by 140
Neonatal development of the rat visual cortex: synaptic function of GABAa receptor α subunits
Bosman, L. W. J., Rosahl, T. W., & Brussaard, A. B. (2002) · The Journal of Physiology · doi:10.1113/jphysiol.2002.026534 · Cited by 126
Baude, A., Bleasdale, C., Dalezios, Y., Somogyi, P., & Klausberger, T. (2007) · Cerebral Cortex · doi:10.1093/cercor/bhl117 · Cited by 137
Sankar, R. (2011) · CNS Drugs · doi:10.2165/11599020-000000000-00000 · Cited by 137
Anaesthetic mechanisms: update on the challenge of unravelling the mystery of anaesthesia
Lugli, A. K., Yost, C. S., & Kindler, C. H. (2009) · European Journal of Anaesthesiology · doi:10.1097/eja.0b013e32832d6b0f · Cited by 135
LEWIS, D. A., CRUZ, D., EGGAN, S., & ERICKSON, S. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1308.008 · Cited by 122
Engin, E., Liu, J., & Rudolph, U. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.08.006 · Cited by 134
Self-citationSelective anxiolysis produced by ocinaplon, a GABA A receptor modulator
LIPPA, A. S., Czobor, P., Stark, J., Beer, B., Kostakis, E., Gravielle, M. C., Bandyopadhyay, S., Russek, S. J., Gibbs, T. T., Farb, D. H., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502579102 · Cited by 134
The Genes and Brains of Mice and Men
Tecott, L. H. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.4.646 · Cited by 133
Locci, A., & Pinna, G. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13843 · Cited by 132
Electrogenic Tuning of the Axon Initial Segment
Clark, B., Goldberg, E. M., & Rudy, B. (2009) · The Neuroscientist · doi:10.1177/1073858409341973 · Cited by 132
Krogsgaard‐Larsen, P., Frølund, B., Liljefors, T., & Ebert, B. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.06.040 · Cited by 131
GABAA-receptor subtypes: a new pharmacology
Möhler, H., Crestani, F., & Rudolph, U. (2001) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(01)00008-x · Cited by 131
Self-citationKaminski, R. M., Gillard, M., Leclercq, K., Hanon, E., Lorent, G., Dassesse, D., Matagne, A., & Klitgaard, H. (2009) · Epilepsia · doi:10.1111/j.1528-1167.2009.02089.x · Cited by 116
Ali, A. B., & Thomson, A. M. (2008) · Cerebral Cortex · doi:10.1093/cercor/bhm160 · Cited by 129
GABAergic analgesia: new insights from mutant mice and subtype-selective agonists
Zeilhofer, H. U., Möhler, H., & Lio, A. D. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.05.007 · Cited by 129
Self-citationMosienko, V., Beis, D. M., Pasqualetti, M., Waider, J., Matthes, S., Qadri, F., Bäder, M., & Alenina, N. V. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.06.005 · Cited by 128
Petroski, R. E., Pomeroy, J. E., Das, R., Bowman, H., Yang, W., Chen, A. P., & Foster, A. C. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.096701 · Cited by 128
Drug targets for cognitive enhancement in neuropsychiatric disorders.
Wallace, T. L., Ballard, T. M., Pouzet, B., Riedel, W. J., & Wettstein, J. G. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.03.022 · Cited by 127
van der Kooij, M. A., Hollis, F., Lozano, L., Zalachoras, I., Abad, S., Zanoletti, O., Grosse, J., Guillot de Suduiraut, I., Canto, C., & Sandi, C. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.135 · Cited by 127
Smith, K. S., & Rudolph, U. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.07.026 · Cited by 128
Self-citationPerucca, E., Bialer, M., & White, H. S. (2023) · CNS Drugs · doi:10.1007/s40263-023-01027-2 · Cited by 127
Chambers, M. S., Atack, J. R., Carling, R. W., Collinson, N., Cook, S. M., Dawson, G. R., Ferris, P., Hobbs, S. C., O'Connor, D. V., Marshall, G. R., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm040863t · Cited by 127
Grasshoff, C., Rudolph, U., & Antkowiak, B. (2005) · Current Opinion in Anaesthesiology · doi:10.1097/01.aco.0000174961.90135.dc · Cited by 126
Self-citationMatsumoto, K., Puia, G., Dong, E., & Pinna, G. (2007) · Stress · doi:10.1080/10253890701200997 · Cited by 126
Fischell, J., Van Dyke, A. M., Kvarta, M. D., LeGates, T. A., & Thompson, S. M. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.112 · Cited by 122
Anticonvulsant effect of wogonin isolated from Scutellaria baicalensis
Park, H. G., Yoon, S. Y., Choi, J. Y., Lee, G. S., Choi, J. H., Shin, C. Y., Son, K. H., Lee, Y. S., Kim, W. K., Ryu, J. H., et al. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.07.011 · Cited by 122
Selective, Orally Active γ-Aminobutyric Acid A α5 Receptor Inverse Agonists as Cognition Enhancers
Sternfeld, F., Carling, R. W., Jelley, R. A., Ladduwahetty, T., Merchant, K. J., Moore, K. W., Reeve, A. J., Street, L. J., O'Connor, D. V., Sohal, B., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm031076j · Cited by 122
Antiepileptic drugs and the developing brain
Kaindl, A. M., Asimiadou, S., Manthey, D., Hagen, M. V. D., Turski, L., & Ikonomidou, C. (2006) · Cellular and Molecular Life Sciences CMLS · doi:10.1007/s00018-005-5348-0 · Cited by 121
Knabl, J., Zeilhofer, U., Crestani, F., Rudolph, U., & Zeilhofer, H. U. (2008) · Pain · doi:10.1016/j.pain.2008.10.015 · Cited by 121
Self-citationLow dose acute alcohol effects on GABAA receptor subtypes
Wallner, M., Hanchar, H. J., & Olsen, R. W. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.05.004 · Cited by 121
Properties of Antiepileptic Drugs in the Treatment of Idiopathic Generalized Epilepsies
Patsalos, P. N. (2005) · Epilepsia · doi:10.1111/j.1528-1167.2005.00326.x · Cited by 121
Collins, I., Moyes, C. R., Davey, W. B., Rowley, M., Bromidge, F. A., Quirk, K., Atack, J. R., McKernan, R. M., THOMPSON, S., Wafford, K. A., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm0110789 · Cited by 121
Nutt, D. J., Besson, M. J., Wilson, S. J., Dawson, G. R., & Lingford-Hughes, A. R. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.08.008 · Cited by 121
From synapse to behavior: rapid modulation of defined neuronal types with engineered GABAA receptors
Wulff, P., Goetz, T., Leppä, E., Linden, A.-M., Renzi, M., Swinny, J. D., Vekovischeva, O. Y., Sieghart, W., Somogyi, P., Korpi, E. R., et al. (2007) · Nature Neuroscience · doi:10.1038/nn1927 · Cited by 120
The GABA-benzodiazepine receptor complex: structure, function, and role in anxiety.
Roy‐Byrne, P. (2005) · PubMed · Cited by 119
Lingford-Hughes, A. R., Hume, S. P., Feeney, A., Hirani, E., Osman, S., Cunningham, V. J., Pike, V. W., Brooks, D. J., & Nutt, D. J. (2002) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200207000-00013 · Cited by 119
The rise of a new GABA pharmacology
Möhler, H. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.10.020 · Cited by 119
Self-citation
Metadata
- Authors
- Rudolph, U., Crestani, F., Benke, D., Brünig, I., Benson, J. A., Fritschy, J.-M., Martin, J. R., Bluethmann, H., & Möhler, H.
- Affiliations
- University of Zurich (CH)
- F. Hoffmann-La Roche AG (CH)
- Corresponding author
- Rudolph, Uwe
- Venue
- Nature
- Published
- 1999-10
- Volume
- 401
- Issue
- 6755
- Pages
- 796-800
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2083623577
- Cited by
- 1,172
- References
- 18
- Citations by year
- 2026: 12 · 2025: 15 · 2024: 20 · 2023: 15 · 2022: 26 · 2021: 20 · 2020: 21 · 2019: 27 · 2018: 46 · 2017: 38 · 2016: 33 · 2015: 25 · 2014: 50 · 2013: 47 · 2012: 54
- FWCI
- 18.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- National Institutes of Health
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- benzodiazepines, GABAA receptor, alpha1 subunit, benzodiazepine binding site, allosteric modulation, diazepam, anxiolytic effects, sedation, amnesia, anticonvulsant activity, ethanol potentiation, myorelaxation, receptor subtypes, limbic system, motor neurons, monoaminergic neurons, drug design
- MeSH terms
- Animals, Anticonvulsants, Arginine, Benzodiazepines, Diazepam, Histidine, Hypnotics and Sedatives, Memory, Mice, Inbred C57BL, Muscle Relaxants, Central, Receptors, GABA-A, Anti-Anxiety Agents, Drug Design, Point Mutation, GABA Modulators, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.